NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM)
Wefel, Jeffrey S, Pugh, Stephanie, Gondi, Vinai, Brown, Paul D, Tome, Wolfgang, Armstrong, Terri S, Bruner, Deborah, Bovi, Joseph, Robinson, Cliff, Khuntia, Deepak, Grosshans, David, Konski, Andre, RoVolume:
66
Langue:
english
Journal:
Neurosurgery
DOI:
10.1093/neuros/nyz310_642
Date:
September, 2019
Fichier:
PDF, 101 KB
english, 2019